DETECT IV - A Study in Patients With HER2-negative Metastatic Breast Cancer and Persisting HER2-negative Circulating Tumor Cells (CTCs).

Clinical trial NCT02035813 · COMPLETED

Trial details

NCT number: NCT02035813
Sponsor: Prof. Wolfgang Janni
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

HER2-negative and Hormone-receptor Positive Metastatic Breast Cancer HER2-negative Circulating Tumor Cells Postmenopausal Female Patients

Start date: 2014-01-01
Primary completion: 2024-01-10
Enrollment: 116

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.